Los Angeles Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Los Angeles Capital Management's ABMD Position: Q4 2022 in Review
Los Angeles Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,104 shares — an estimated $517K sold.
Los Angeles Capital Management first reported a position in ABMD in Q3 2015 and held it in 22 quarters. The position peaked at $25.8M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Los Angeles Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Los Angeles Capital Management sold 2,104 Abiomed Inc shares in Q4 2022, an estimated $517K.
- Los Angeles Capital Management first reported a position in Abiomed Inc in Q3 2015 and held it in 22 quarters.
- Los Angeles Capital Management's Abiomed Inc position peaked at $25.8M in Q4 2020.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Los Angeles Capital Management's 13F filing for Q4 2022, filed 6 Feb 2023.